Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Long-Term Cardiovascular Outcomes of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Using an
Abhishek Chakraborty1,2, Jason N Johnson3,4,5, Jonathan Spagnoli6
1Division of Pediatric Cardiology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, USA. dr.abhishek.chakraborty@gmail.com.
Insights
Multisystem inflammatory syndrome in children (MIS-C) can cause heart issues. While most cardiovascular problems resolve within six weeks, some children may experience persistent diastolic dysfunction, coronary artery abnormalities, or myocardial scarring, necessitating long-term monitoring.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Cardiovascular involvement is a significant cause of morbidity in children with Multisystem Inflammatory Syndrome (MIS-C).
- Understanding the long-term cardiovascular sequelae of MIS-C is crucial for patient management.
Purpose of the Study:
- To identify and characterize the long-term cardiovascular manifestations in children following MIS-C.
- To assess the resolution patterns of cardiac dysfunction and abnormalities post-MIS-C.
Main Methods:
- Prospective follow-up of 80 pediatric intensive care unit patients with MIS-C for one year.
- Evaluation included cardiac biomarkers (troponin, BNP), ECG, echocardiography, cardiovascular magnetic resonance (CMR), and graded-exercise stress testing (GXT).
Main Results:
- Elevated BNP and troponin levels at disease peak normalized by 6 weeks post-discharge.
- Systolic dysfunction improved significantly by discharge, with complete resolution in most by 2 weeks.
- Coronary artery abnormalities resolved in most by 2 weeks post-discharge, with one persistent giant aneurysm at 1 year. CMR revealed persistent late gadolinium enhancement in 17.4% of patients at 6 months.
Conclusions:
- Cardiovascular manifestations of MIS-C are heterogeneous, with most resolving within 6 weeks.
- A small subset of patients may experience persistent diastolic dysfunction, coronary artery abnormalities, or myocardial scarring.
- Structured long-term follow-up is warranted for children with MIS-C to monitor for potential chronic cardiovascular complications.
Abstract:
Cardiovascular involvement is a major cause of inpatient and intensive care unit morbidity related to Multisystem inflammatory syndrome in children (MIS-C). The objective of this study was to identify long-term cardiovascular manifestations of MIS-C. We included 80 consecutive patients admitted to the intensive care unit with MIS-C who were evaluated for a year in our follow-up clinic using an institution protocol. The outcome measures were cardiac biomarkers (troponin and BNP), electrocardiogram changes, echocardiographic findings cardiovascular magnetic resonance (CMR) and graded-exercise stress test (GXT) findings. The cohort included patients aged between 6 months and 17 years (median 9 years; 48.8% females). At the peak of the disease 81.3% had abnormal BNP and 58.8% had troponin leak which reduced to 33.8% and 18.8% respectively at discharge with complete normalization by 6 weeks post-discharge. At admission 33.8% had systolic dysfunction, which improved to 11.3% at discharge with complete resolution by 2 weeks. Coronary artery abnormalities were seen in 17.5% during the illness with complete resolution by 2 weeks post discharge except one (1.9%) with persistent giant aneurysm at 1 year-follow up. CMR was performed at 6 months in 23 patient and demonstrated 4 patients with persistent late gadolinium enhancement (17.4%). Normal exercise capacity with no ectopy was seen in the 31 qualifying patients that underwent a GXT. There is significant heterogeneity in the cardiovascular manifestations of MIS-C. Although majority of the cardiovascular manifestations resolve within 6 weeks, diastolic dysfunction, CAA and myocardial scar may persist in a small subset of patients warranting a structured long-term follow-up strategy.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations